Journal of Clinical Ligand Assay

Risk Ratios for Prognosis: Statistical Flaws (With hs-C-reactive Protein as an Example of Inflammatory Biomarkers in Coronary Disease)
pp. 3-9(7)
Author: Levinson, Stanley S.

Clinical Trial Design: Integrating Biomarkers into Drug Development
pp. 10-19(10)
Author: Aziz, Kaiser J.

Clinical Applications of Procalcitonin (PCT)
pp. 20-28(9)
Author: Uettwiller-Geiger, Denise L.

Rapid Cell Division as an Etiology of Severe Hypophosphatemia
pp. 29-32(4)
Authors: Shah, Veena V.; Kiechle, Frederick L.

Evaluation of Epithelial Growth Factor Receptor (EGFR) Expression in Benign and Advanced Stage Squamous Cell Carcinomas of the Larynx
pp. 33-36(4)
Authors: Saglam, Ozlen; Shah, Veena; Worsham, Maria J.

Effects of Immobilization Chemistry on Enzyme-Linked Aptamer Assays for Leishmania Surface Antigens
pp. 37-43(7)
Authors: Bruno, John G.; Carrillo, Maria P.; Phillips, Taylor

Time Adjusted Sensitivity Analysis: A New Statistical Test for the Optimization of Delta Check Rules
pp. 44-54(11)
Authors: Sampson, Maureen L.; Rehak, Nadja N.; Sokoll, Lori J.; Ruddel, Mark E.; Gerhardt, Gregory A.; Remaley, Alan T.

Clinical Pathology and Revenue: Part II
pp. 55-58(4)
Author: Kiechle, Frederick L.